Canadian Biotech Companyâs Nasal Spray Could Provide Important Breakthrough In Covid-19 Treatment; Clinical Trials In Canada And UK Show Encouraging Results
by Swarajya Staff - Apr 9, 2021 10:14 AM
Clinical trials have shown that NONS is an effective treatment.
Snapshot
NONS could prevent the transmission of Covid-19, shorten its course, as well as reduce the severity of the symptoms and damage in those already infected.
Canadian biotech company SaNOtize Research & Development Corp (SaNOtize) has developed nitric oxide nasal spray (NONS). It can protect people from viruses that enter the body through the upper nasal pathways.
According to the trial findings, this could help the world to fight the battle against the coronavirus pandemic.